Nikkiso reports strong Q3 profit growth across all business segments

For the nine months ended September 30, 2025, Nikkiso reported revenue of 152,278 million yen, a slight increase of 0.4% year-on-year. Operating profit saw a substantial rise of 119.6% to 8,211 million yen, while profit before tax jumped 72.7% to 7,985 million yen. Profit for the period attributable to owners of the company increased by 75.0% to 7,331 million yen, resulting in basic earnings per share of 110.65 yen.

The Industrial Business experienced year-on-year profit growth due to steady order execution, high-profit projects, and sales price adjustments. The Aerospace Business achieved both revenue and profit growth, recovering from earlier declines thanks to industry-wide production recovery. The Medical Business also saw increased year-on-year profit, primarily from its overseas hemodialysis operations.

Total assets as of September 30, 2025, reached 328,354 million yen, an increase of 2,790 million yen from the previous fiscal year-end. Total equity also grew by 7,525 million yen to 149,531 million yen. The company's full-year financial forecast for December 31, 2025, remains unchanged, projecting revenue of 230,500 million yen and operating profit of 14,000 million yen.